[{"id":"2fc1726b-7bbd-4f7d-9a95-7447645c8195","acronym":"","url":"https://clinicaltrials.gov/study/NCT03985072","created_at":"2021-01-18T19:35:56.001Z","updated_at":"2024-07-02T16:36:16.686Z","phase":"Phase 1","brief_title":"Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor","source_id_and_acronym":"NCT03985072","lead_sponsor":"Andes Biotechnologies","biomarkers":" HER-2 • KRAS • NRAS","pipe":" | ","alterations":" RAS wild-type • NRAS wild-type","tags":["HER-2 • KRAS • NRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RAS wild-type • NRAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e mulnitorsen (Andes-1537)"],"overall_status":"Completed","enrollment":" Enrollment 67","initiation":"Initiation: 04/26/2019","start_date":" 04/26/2019","primary_txt":" Primary completion: 02/17/2022","primary_completion_date":" 02/17/2022","study_txt":" Completion: 02/17/2022","study_completion_date":" 02/17/2022","last_update_posted":"2022-02-24"}]